J.A.M.J.L. Janssen

J.A.M.J.L. Janssen is a Researcher in the Department of Internal Medicine at Erasmus MC, a leading academic medical center in the Netherlands. The research profile indicates active contributions to the fields of endocrinology, metabolism, and molecular medicine.

The research interests of J.A.M.J.L. Janssen center on metabolic syndrome, type 2 diabetes, ectopic fat deposition, hyperinsulinemia, and the insulin/IGF-I signaling pathway. Additional focus includes receptor pharmacology, particularly the interplay between IGF-I and TSH receptors in thyroid eye disease. Research also extends to overnutrition, ultra-processed foods, and the metabolic consequences of Westernization. These interests are reflected in a high volume of recent review articles and commentaries in prominent journals.

The recent publications demonstrate a strong trend toward synthesizing evidence on metabolic dysregulation, advocating for paradigm shifts in diabetes management, and exploring molecular mechanisms of disease. Work frequently appears in journals such as International Journal of Molecular Sciences and The Lancet Regional Health - Europe, indicating high impact and policy relevance.

While no specific scientific awards are listed in the provided text, the research has been cited extensively (e.g., 38 citations for a 2022 article) and picked up by multiple news outlets and blogs, suggesting recognition in both academic and public spheres.

J.A.M.J.L. Janssen has supervised at least three research projects, as indicated by the 'Supervised Work (3)' metric, though specific student names and grant details are not available. The scholarly output includes collaborations with international researchers, such as L. Girnita and T.J. Smith.

The research is conducted within the Department of Internal Medicine at Erasmus MC, with no additional lab or team structure described in the text.